"(The LogPad) is a great tool to capture time-sensitive data. In daily symptom diaries, recall bias is a real problem and it's difficult to assess actual compliance rates. The LogPad has worked out great - the patients have been very happy with it, and from our perspective it improves the accuracy of the data."

Nadia Hansel, MD, MPH
Instructor, Division of Pulmonary and Critical Care Medicine at Johns Hopkins University
Asthmatx AIR2 Trial

Read more on what people are saying about PHT.

PHT and Sucampo Pharmaceuticals Present ePRO/EDC Data Integration Case Study at CBI Premier Conference on PRO

BOSTON, MA – January 10 – PHT Corporation and Sucampo Pharmaceuticals (Nasdaq:SCMP) introduced an innovative eClinical data integration case study at the Center for Business Intelligence (CBI)’s Premier Conference on Patient Reported Outcomes recently in Washington, D.C. For more details on eClinical data integration, review PHT’s latest Insights newsletter at www.phtcorp.com.

PHT is the leading provider of electronic patient reported outcome (ePRO) solutions used in more than 330 clinical trials worldwide. Sucampo is a specialty pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body.

The PHT and Sucampo case study detailed the integration of eDiary data into a leading EDC system to consolidate key clinical data for review by sites and CRAs. The lively discussion following the presentation covered additional options for data integration including clinical data management systems, automatic eligibility calculations, and other PRO measurement devices.

Phil Lee, PHT President and CEO, said, “We welcomed the opportunity to present with a forward-thinking industry leader such as Sucampo, and were very pleased by the high attendance and extraordinary level of interest in our ePRO technology.”

About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 330 clinical trials around the world. The company’s proven LogPad® and StudyPad® Systems deliver the voice of the patient – directly and without distortion – with reliable and timely self-reported data. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least eight NDA submissions, with five known approvals, to date. To learn more about how study sponsors worldwide are using ePRO to improve data quality, conduct smaller trials, and manage patient safety, enrollment and compliance in real time, visit www.phtcorp.com.

PHT, LogPad and StudyPad are among the registered trademarks and trademarks of PHT Corporation.

Contact: Brenda Nashawaty, bnashawaty@phtcorp.com, 617-688-3253

###

« Back to the news listing

Contact Us Products & Solutions Experience PHT Why ePRO? Resources Company Sitemap
® 2010 PHT Corporation